Project Number 5R01AG062617-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Discovery of Selective Inhibitors for the EphA4 Kinase Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator SERGIENKO, EDUARD A. Principal Investigator First Name EDUARD Principal Investigator Last Name SERGIENKO Awardee Organization SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-19-147: Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) FY Overall Cost $754,237 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
